scorecardresearch
Add as a preferred source on Google
Wednesday, February 4, 2026
TopicRanitidine

Topic: ranitidine

US lawsuit settlement puts spotlight back on ranitidine. India still undecided on ‘cancer-risk’ drug

Ranitidine still sold as popular heartburn medicine in India despite being banned or suspended in US, Europe & Australia. It was dropped from essential medicines list last year.

Ranitidine off essential meds list but India still sells ‘cancer-causing’ antacid shunned by world

Known as Rantac and Zantac in India, ranitidine is still a heartburn go-to. But several countries suspended its sale in 2020 after it was found to contain cancer-causing compound.

Explained: Why India, US haven’t recalled acidity drug Ranitidine but France & Canada have

US expert who flagged the presence of cancer-causing NDMA in Ranitidine says sales must stop permanently.

On Camera

Why Rahul Gandhi wasn’t allowed to read an excerpt from General Naravane’s memoir

General MM Naravane’s memoir—Four Stars of Destiny—reveals that he was left hanging by political leadership for more than two hours as Chinese tanks drove towards Indian positions.

Trade deal with US likely to lift Rupee & stocks, say investors

New Delhi: India’s agreement with the US to buy $500 billion-worth of goods over five years includes an existing pipeline of projects, as well...

Adani Defence teams up with Italy’s Leonardo to tap India’s mega helicopter market

The partnership will focus on targeting the Indian Armed Forces' requirements, particularly for Leonardo's AW169M and AW109 TrekkerM helicopters.

Swiss report should now close Op Sindoor debate. Knowing when to stop the fight is key too

The key to fighting a war successfully, or even launching it, is a clear objective. That’s an entirely political call. It isn’t emotional or purely military.